Aarti Pharmalabs informs about disclosure

17 Dec 2024 Evaluate
Aarti Pharmalabs has informed that the Company has received from Constituted Attorney(ies) representing the Persons prescribed in Schedule I of Annexure to the agreement an intimation under Regulation 30A(1) of the Listing Regulations read with Clause 5A, Para A, Part A, Schedule III of the Listing Regulations on December 16, 2024. The details as required pursuant to Regulation 30 read with Schedule Ill of the Listing Regulations read with SEBI Circular No. SEBI/HO/CFD/CFD-PoD-1/P/CIR/2023/123 dated July 13, 2023 are also mentioned in the attached agreement. The below information will also be available on the website of the Company at www.aartipharmalabs.com.

The above information is a part of company’s filings submitted to BSE.

Aarti Pharmalabs Share Price

734.60 -19.65 (-2.61%)
25-Apr-2025 15:09 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1787.80
Dr. Reddys Lab 1175.90
Cipla 1526.20
Lupin 2018.20
Zydus Lifesciences 860.60
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
×
Please wait your portfolio is updating...